Search Results

There are 4306 results for: content related to: Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients

  1. Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels

    The Prostate

    Volume 75, Issue 11, August 1, 2015, Pages: 1216–1226, Alba Font-Tello, Núria Juanpere, Silvia de Muga, Marta Lorenzo, José A. Lorente, Lluis Fumado, Laia Serrano, Sergio Serrano, Josep Lloreta and Silvia Hernández

    Version of Record online : 4 MAY 2015, DOI: 10.1002/pros.23004

  2. Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer

    The Journal of Pathology

    Volume 230, Issue 2, June 2013, Pages: 174–183, Christopher Weier, Michael C Haffner, Timothy Mosbruger, David M Esopi, Jessica Hicks, Qizhi Zheng, Helen Fedor, William B Isaacs, Angelo M. De Marzo, William G Nelson and Srinivasan Yegnasubramanian

    Version of Record online : 13 MAY 2013, DOI: 10.1002/path.4186

  3. Combined analysis of TMPRSS2–ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer

    Genes, Chromosomes and Cancer

    Volume 51, Issue 8, August 2012, Pages: 781–791, Rasa Sabaliauskaite, Sonata Jarmalaite, Donatas Petroska, Darius Dasevicius, Arvydas Laurinavicius, Feliksas Jankevicius and Juozas R. Lazutka

    Version of Record online : 16 APR 2012, DOI: 10.1002/gcc.21963

  4. Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma

    Molecular Carcinogenesis

    Volume 54, Issue 9, September 2015, Pages: 900–907, Lisha Wang, Sean R. Williamson, Shaobo Zhang, Jiaoti Huang, Rodolfo Montironi, Darrell D. Davison, Mingsheng Wang, Jorge L. Yao, Antonio Lopez-Beltran, Adeboye O. Osunkoya, Gregory T. MacLennan, Lee Ann Baldridge, Xiang Du and Liang Cheng

    Version of Record online : 29 APR 2014, DOI: 10.1002/mc.22162

  5. Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset

    The Prostate

    Volume 76, Issue 9, June 15, 2016, Pages: 854–865, Silvia Hernández, Alba Font-Tello, Núria Juanpere, Silvia de Muga, Marta Lorenzo, Marta Salido, Lluís Fumadó, Laia Serrano, Lluís Cecchini, Sergio Serrano and Josep Lloreta

    Version of Record online : 9 MAR 2016, DOI: 10.1002/pros.23176

  6. In situ sequencing identifies TMPRSS2–ERG fusion transcripts, somatic point mutations and gene expression levels in prostate cancers

    The Journal of Pathology

    Volume 234, Issue 2, October 2014, Pages: 253–261, Sara Kiflemariam, Marco Mignardi, Muhammad Akhtar Ali, Anders Bergh, Mats Nilsson and Tobias Sjöblom

    Version of Record online : 4 AUG 2014, DOI: 10.1002/path.4392

  7. Immunohistochemical ETS-related gene detection in a Japanese prostate cancer cohort: Diagnostic use in Japanese prostate cancer patients

    Pathology International

    Volume 61, Issue 7, July 2011, Pages: 409–414, Bungo Furusato, Geert J.H.L. van Leenders, Jan Trapman, Takahiro Kimura, Shin Egawa, Hiroyuki Takahashi, Masakuni Furusato, Tapio Visakorpi and Hiroshi Hano

    Version of Record online : 8 JUN 2011, DOI: 10.1111/j.1440-1827.2011.02675.x

  8. You have free access to this content
    TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis

    APMIS

    Volume 117, Issue 8, August 2009, Pages: 575–582, KARI ROSTAD, OLAF J. C. HELLWINKEL, SVEIN A. HAUKAAS, OLE J. HALVORSEN, ANNE M. ØYAN, ALEXANDER HAESE, LARS BUDÄUS, HEIKO ALBRECHT, LARS A. AKSLEN, THORSTEN SCHLOMM and KARL-HENNING KALLAND

    Version of Record online : 8 JUL 2009, DOI: 10.1111/j.1600-0463.2009.02517.x

  9. Morphological features of TMPRSS2–ERG gene fusion prostate cancer

    The Journal of Pathology

    Volume 212, Issue 1, May 2007, Pages: 91–101, J-M Mosquera, S Perner, F Demichelis, R Kim, MD Hofer, KD Mertz, PL Paris, J Simko, C Collins, TA Bismar, AM Chinnaiyan and MA Rubin

    Version of Record online : 23 MAR 2007, DOI: 10.1002/path.2154

  10. Prognostic value of ERG oncoprotein in prostate cancer recurrence and cause-specific mortality

    The Prostate

    Volume 73, Issue 9, June 2013, Pages: 905–912, E. Sophie Spencer, Richard B. Johnston, Ryan R. Gordon, Jared M. Lucas, Cigdem Himmetoglu Ussakli, Antonio Hurtado-Coll, Shiv Srivastava, Peter S. Nelson and Christopher R. Porter

    Version of Record online : 17 JAN 2013, DOI: 10.1002/pros.22636

  11. Immunocytochemical detection of ERG expression in exfoliated urinary cells identifies with high specificity patients with prostate cancer

    BJU International

    Volume 117, Issue 4, April 2016, Pages: 686–696, Raj P. Pal, Roger C. Kockelbergh, John Howard Pringle, Lara Cresswell, Roger Hew, John P. Dormer, Colin Cooper, John Kilian Mellon, Julian G. Barwell and Edward J. Hollox

    Version of Record online : 29 JUL 2015, DOI: 10.1111/bju.13184

  12. Diagnostic and prognostic molecular biomarkers for prostate cancer

    Histopathology

    Volume 60, Issue 1, January 2012, Pages: 125–141, Glen Kristiansen

    Version of Record online : 23 DEC 2011, DOI: 10.1111/j.1365-2559.2011.04083.x

  13. You have free access to this content
    High-resolution ERG-expression profiling on GeneChip exon 1.0 ST arrays in primary and castration-resistant prostate cancer

    BJU International

    Volume 111, Issue 5, May 2013, Pages: 836–842, Frank P. Smit, Maciej Salagierski, Sander Jannink and Jack A. Schalken

    Version of Record online : 12 APR 2013, DOI: 10.1111/bju.12119

  14. Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis

    The Prostate

    Volume 73, Issue 2, January 2013, Pages: 113–120, Grégoire Robert, Sander Jannink, Frank Smit, Tilly Aalders, Daphne Hessels, Ruben Cremers, Peter F. Mulders and Jack A. Schalken

    Version of Record online : 5 JUN 2012, DOI: 10.1002/pros.22546

  15. You have full text access to this OnlineOpen article
    Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth

    Cancer Science

    Volume 105, Issue 10, October 2014, Pages: 1272–1278, Daisuke Obinata, Akiko Ito, Kyoko Fujiwara, Ken-Ichi Takayama, Daisaku Ashikari, Yasutaka Murata, Kenya Yamaguchi, Tomohiko Urano, Tetsuya Fujimura, Noboru Fukuda, Masayoshi Soma, Takayoshi Watanabe, Hiroki Nagase, Satoshi Inoue and Satoru Takahashi

    Version of Record online : 17 SEP 2014, DOI: 10.1111/cas.12493

  16. Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers

    The Prostate

    Volume 74, Issue 16, December 2014, Pages: 1647–1654, Achim Fleischmann, Outi R. Saramäki, Inti Zlobec, Diana Rotzer, Vera Genitsch, Roland Seiler, Tapio Visakorpi and George N. Thalmann

    Version of Record online : 22 SEP 2014, DOI: 10.1002/pros.22882

  17. You have free access to this content
    Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer

    BJU International

    Volume 114, Issue 4, October 2014, Pages: 608–616, Luis Martínez-Piñeiro, Jack A. Schalken, Patrick Cabri, Pascal Maisonobe, Alexandre de la Taille and on behalf of the Triptocare Study Group

    Version of Record online : 4 APR 2014, DOI: 10.1111/bju.12542

  18. Molecular genetics of prostate cancer: emerging appreciation of genetic complexity

    Histopathology

    Volume 60, Issue 1, January 2012, Pages: 187–198, Christopher E Barbieri, Francesca Demichelis and Mark A Rubin

    Version of Record online : 23 DEC 2011, DOI: 10.1111/j.1365-2559.2011.04041.x

  19. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer

    The Prostate

    Volume 75, Issue 9, June 15, 2015, Pages: 897–906, Rebecca E. Graff, Andreas Pettersson, Rosina T. Lis, Natalie DuPre, Kristina M. Jordahl, Elizabeth Nuttall, Jennifer R. Rider, Michelangelo Fiorentino, Howard D. Sesso, Stacey A. Kenfield, Massimo Loda, Edward L. Giovannucci, Bernard Rosner, Paul L. Nguyen, Christopher J. Sweeney, Lorelei A. Mucci and on behalf of the Transdisciplinary Prostate Cancer Partnership ToPCaP

    Version of Record online : 1 MAR 2015, DOI: 10.1002/pros.22973

  20. ERG expression in prostate cancer: The prognostic paradox

    The Prostate

    Volume 74, Issue 15, November 2014, Pages: 1481–1487, Michael Taris, Jacques Irani, Pascal Blanchet, Luc Multigner, Xavier Cathelineau and Gaelle Fromont

    Version of Record online : 29 AUG 2014, DOI: 10.1002/pros.22863